Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)
This study has been completed.
Sponsor:
DUSA Pharmaceuticals, Inc.
Information provided by (Responsible Party):
DUSA Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01475955
First received: November 15, 2011
Last updated: November 21, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine if Levulan Photodynamic Therapy (PDT) is safe and effective in the treatment of actinic keratosis when applied to broad areas on the face and scalp for 1, 2 and 3 hours.
| Condition | Intervention | Phase |
|---|---|---|
|
Actinic Keratosis |
Drug: Broad Area ALA 1-hour incubation Drug: Broad Area ALA 2-hr incubation Drug: broad area ALA 3-hour incubation Drug: Spot application ALA 2 hour incubation Drug: Vehicle PDT |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | A Phase II Study of Photodynamic Therapy With LEVULAN® Topical Solution + Blue Light Versus LEVULAN® Topical Solution Vehicle + Blue Light Using Spot and Broad Area Application and Incubation Times of 1, 2 and 3 Hours for the Treatment of Multiple Actinic Keratoses on the Face or Scalp |
Resource links provided by NLM:
Further study details as provided by DUSA Pharmaceuticals, Inc.:
Primary Outcome Measures:
- Complete clearance Rate [ Time Frame: Week 12 ] [ Designated as safety issue: No ]The proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area
Secondary Outcome Measures:
- Complete clearance rate [ Time Frame: Week 4 ] [ Designated as safety issue: No ]The proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area
- Complete clearance rate [ Time Frame: Week 8 ] [ Designated as safety issue: No ]The proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area
- Complete clearance rate [ Time Frame: Week 24 ] [ Designated as safety issue: No ]the proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area
- Partial clearance rate [ Time Frame: Baseline, Week 4 ] [ Designated as safety issue: No ]proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.
- Partial clearance rate [ Time Frame: Baseline, Week 8 ] [ Designated as safety issue: No ]proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.
- Partial clearance rate [ Time Frame: Baseline, Week 12 ] [ Designated as safety issue: No ]proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.
- Partial clearance rate [ Time Frame: Baseline Week 24 ] [ Designated as safety issue: No ]proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.
- Percent change in AK number [ Time Frame: Baseline, Week 4 ] [ Designated as safety issue: No ]
- Percent change in AK number [ Time Frame: Baseline, Week 8 ] [ Designated as safety issue: No ]
- Percent change in AK number [ Time Frame: Baseline, Week 12 ] [ Designated as safety issue: No ]
- Percent change in AK number [ Time Frame: Baseline, Week 24 ] [ Designated as safety issue: No ]
- Subject satisfaction score [ Time Frame: Week 24 ] [ Designated as safety issue: No ]
0 = no improvement or worsening (not satisfied at all)
- = slight improvement (slightly satisfied)
- = moderate improvement (moderately satisfied)
- = excellent improvement (very satisfied)
- Hyperpigmentation at Visit 2 [ Time Frame: 24-48 Hours after PDT #1 ] [ Designated as safety issue: Yes ]HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
- Hyperpigmentation at Visit 3 [ Time Frame: Week 2 ] [ Designated as safety issue: Yes ]HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
- Hyperpigmentation at Visit 4 [ Time Frame: Week 4 ] [ Designated as safety issue: Yes ]HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
- Hyperpigmentation at Visit 5 [ Time Frame: Week 8 ] [ Designated as safety issue: Yes ]HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
- Hyperpigmentation at Visit 6 [ Time Frame: Week 12 ] [ Designated as safety issue: Yes ]HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
- Hyperpigmentation at Visit 7 [ Time Frame: Week 24 ] [ Designated as safety issue: Yes ]HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
- Hypopigmentation at Visit 2 [ Time Frame: 24-48 Hours after PDT #1 ] [ Designated as safety issue: Yes ]HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
- Hypopigmentation at Visit 3 [ Time Frame: Week 2 ] [ Designated as safety issue: Yes ]HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
- Hypopigmentation at Visit 4 [ Time Frame: Week 4 ] [ Designated as safety issue: Yes ]HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
- Hypopigmentation at Visit 5 [ Time Frame: Week 8 ] [ Designated as safety issue: Yes ]HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
- Hypopigmentation at Visit 6 [ Time Frame: Week 12 ] [ Designated as safety issue: Yes ]HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
- Hypopigmentation at Visit 7 [ Time Frame: Week 24 ] [ Designated as safety issue: Yes ]HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
- Erythema Post-Light Treatment [ Time Frame: 5 minutes after PDT #1 ] [ Designated as safety issue: Yes ]Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
- Erythema at Visit 2 [ Time Frame: 24-48 hours after PDT #1 ] [ Designated as safety issue: Yes ]Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
- Erythema at Visit 3 [ Time Frame: Week 2 ] [ Designated as safety issue: Yes ]Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
- Erythema at Visit 4 [ Time Frame: Week 4 ] [ Designated as safety issue: Yes ]Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
- Erythema at Visit 5 [ Time Frame: Week 8 ] [ Designated as safety issue: Yes ]Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
- Erythema at Visit 6 [ Time Frame: Week 12 ] [ Designated as safety issue: Yes ]Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
- Erythema at Visit 7 [ Time Frame: Week 24 ] [ Designated as safety issue: Yes ]Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
- Edema Post-Light Treatment [ Time Frame: 5 minutes after PDT #1 ] [ Designated as safety issue: Yes ]EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
- Edema at Visit 2 [ Time Frame: 24-48 hours after PDT #1 ] [ Designated as safety issue: Yes ]EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
- Edema at Visit 3 [ Time Frame: Week 2 ] [ Designated as safety issue: Yes ]EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
- Edema at Visit 4 [ Time Frame: Week 4 ] [ Designated as safety issue: Yes ]EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
- Edema at Visit 5 [ Time Frame: Week 8 ] [ Designated as safety issue: Yes ]EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
- Edema at Visit 6 [ Time Frame: Week 12 ] [ Designated as safety issue: Yes ]EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
- Edema at Visit 7 [ Time Frame: Week 24 ] [ Designated as safety issue: Yes ]EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
- Stinging/Burning During Light Treatment [ Time Frame: During PDT #1 (most intense sensation) ] [ Designated as safety issue: Yes ]STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.
- Stinging/Burning Post-Light Treatment [ Time Frame: 5 minutes after PDT #1 ] [ Designated as safety issue: Yes ]STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
- Stinging/Burning at Visit 2 [ Time Frame: 24-48 hours after PDT #1 ] [ Designated as safety issue: Yes ]STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
- Stinging/Burning at Visit 3 [ Time Frame: Week 2 ] [ Designated as safety issue: Yes ]STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
- Stinging/Burning at Visit 4 [ Time Frame: Week 4 ] [ Designated as safety issue: Yes ]STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
- Stinging/Burning at Visit 5 [ Time Frame: Week 8 ] [ Designated as safety issue: Yes ]STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
- Stinging/Burning at Visit 6 [ Time Frame: Week 12 ] [ Designated as safety issue: Yes ]STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
- Stinging/Burning at Visit 7 [ Time Frame: Week 24 ] [ Designated as safety issue: Yes ]STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
- Scaling and Dryness at Visit 2 [ Time Frame: 24-48 hours after PDT #1 ] [ Designated as safety issue: Yes ]SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
- Scaling and Dryness at Visit 3 [ Time Frame: Week 2 ] [ Designated as safety issue: Yes ]SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
- Scaling and Dryness at Visit 4 [ Time Frame: Week 4 ] [ Designated as safety issue: Yes ]SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
- Scaling and Dryness at Visit 5 [ Time Frame: Week 8 ] [ Designated as safety issue: Yes ]SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
- Scaling and Dryness at Visit 6 [ Time Frame: Week 12 ] [ Designated as safety issue: Yes ]SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
- Scaling and Dryness at Visit 7 [ Time Frame: Week 24 ] [ Designated as safety issue: Yes ]SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
- Oozing/Vesiculation/Crusting at Visit 2 [ Time Frame: 24-48 hours after PDT #1 ] [ Designated as safety issue: Yes ]OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
- Oozing/Vesiculation/Crusting at Visit 3 [ Time Frame: Week 2 ] [ Designated as safety issue: Yes ]OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
- Oozing/Vesiculation/Crusting at Visit 4 [ Time Frame: Week 4 ] [ Designated as safety issue: Yes ]OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
- Oozing/Vesiculation/Crusting at Visit 5 [ Time Frame: Week 8 ] [ Designated as safety issue: Yes ]OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
- Oozing/Vesiculation/Crusting at Visit 6 [ Time Frame: Week 12 ] [ Designated as safety issue: Yes ]OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
- Oozing/Vesiculation/Crusting at Visit 7 [ Time Frame: Week 24 ] [ Designated as safety issue: Yes ]OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
| Enrollment: | 235 |
| Study Start Date: | December 2011 |
| Study Completion Date: | November 2012 |
| Primary Completion Date: | November 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Broad Area ALA 1-hour |
Drug: Broad Area ALA 1-hour incubation
20% ALA, broad area, 1 hour incubation
Other Name: Levulan
|
| Experimental: Broad Area ALA 2-hour |
Drug: Broad Area ALA 2-hr incubation
20% ALA broad area 2-hour incubation
Other Name: Levulan
|
| Experimental: Broad Area ALA 3-hour |
Drug: broad area ALA 3-hour incubation
20% ALA broad area 3 hour incubation
Other Name: Levulan
|
| Experimental: Spot ALA 2-hour |
Drug: Spot application ALA 2 hour incubation
20% ALA spot application 2 hour incubation
Other Name: Levulan
|
|
Placebo Comparator: Vehicle PDT
VEH group will be randomized (1:1:1:1) to be balanced for the four active groups; broad area application for 1, 2 or 3 hours or spot application for 2 hours prior to BLUE light treatment. Subjects receiving VEH will be considered a single treatment group.
|
Drug: Vehicle PDT
Levulan Kerastick containing vehicle ingredients only.VEH group will be randomized (1:1:1:1) to be balanced for the four active groups; broad area application for 1, 2 or 3 hours or spot application for 2 hours prior to BLUE light treatment. Subjects receiving VEH will be considered a single treatment group.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- 6-20 Grade 1/2 AKs on the face or scalp
- a history of AK therapy within the treatment area at least twice in the two years prior to study entry
Exclusion Criteria:
- Pregnancy
- Grade 3 AKs or atypical AKs (e.g., AK > 1 cm2 in size) within the Treatment Area
- lesions suspicious for skin cancer (skin cancer not ruled out by biopsy) or untreated skin cancers within the Treatment Area
- plans to be exposed to artificial tanning devices or excessive sunlight during the trial
- Subject is immunosuppressed
- unsuccessful outcome from previous ALA-PDT therapy
- history of cutaneous photosensitization, porphyria, hypersensitivity to porphyrins or photodermatosis
- skin pathology or condition which could interfere with the evaluation of the test product or requires the use of interfering topical or systemic therapy
- skin pathology or condition that could interfere with the evaluation of the test product or requires the use of interfering topical or systemic therapy
- any condition which would make it unsafe for the subject to participate in this research study
- currently enrolled in an investigational drug or device study
- has received an investigational drug or been treated with an investigational device within 30 days prior to the initiation of treatment
- known sensitivity to one or more of the vehicle components (ethyl alcohol, isopropyl alcohol, laureth 4, polyethylene glycol)
Subject has;
- an active herpes simplex infection OR
- a history of 2 or more outbreaks within the past 12 months, in the Treatment Area
use of the following topical preparations on the extremities to be treated:
- Keratolytics including urea (greater than 5%), alpha hydroxyacids [e.g.glycolic acid, lactic acid, etc. greater than 5%], salicylic acid (greater than 2%) within 2 days of initiation of treatment.
- Cryotherapy within 2 weeks of initiation of treatment
- Retinoids, including tazarotene, adapalene, tretinoin, retinol, within 4 weeks of initiation of treatment.
- Microdermabrasion, laser ablative treatments, ALA-PDT, chemical peels, 5-FU, diclofenac, imiquimod or other topical treatments for AK within 8 weeks of initiation of treatment.
- Two or more ALA PDT treatments in the past 6 months
- use of systemic retinoid therapy within 6 months of initiation of treatment.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01475955
Locations
| United States, California | |
| UCSD Dermatology Perlman Ambulatory Clinic | |
| La Jolla, California, United States, 92037 | |
| Dermatology Research Associates | |
| Los Angeles, California, United States, 90045 | |
| Therapeutics Clinical Research | |
| San Diego, California, United States, 92123 | |
| United States, Idaho | |
| Northwest Clinical Trials, Inc. | |
| Boise, Idaho, United States, 83704 | |
| United States, Illinois | |
| Altman Dermatology Associates | |
| Arlington Heights, Illinois, United States, 60005 | |
| United States, Indiana | |
| The Indiana Clinical Trials Center, PC | |
| Plainfield, Indiana, United States, 46168 | |
| United States, Minnesota | |
| Minnesota Clinical Study Center | |
| Fridley, Minnesota, United States, 55432 | |
| United States, Ohio | |
| Dermatology Research Center of Cincinnati | |
| Cincinnati, Ohio, United States, 45220 | |
| United States, Oregon | |
| Oregon Medical Research Center, PC | |
| Portland, Oregon, United States, 97223 | |
| United States, Tennessee | |
| Tennessee Clinical Research Center | |
| Nashville, Tennessee, United States, 37215 | |
| United States, Texas | |
| DermResearch, Inc. | |
| Austin, Texas, United States, 78759 | |
| Suzanne Bruce and Associates, P.A.,The Center for Skin Research | |
| Houston, Texas, United States, 77056 | |
| United States, Virginia | |
| Virginia Clinical Research Inc | |
| Norfolk, Virginia, United States, 23507 | |
Sponsors and Collaborators
DUSA Pharmaceuticals, Inc.
Investigators
| Study Director: | Stuart Marcus, MD, PhD | DUSA Pharmaceuticals, Inc. |
More Information
No publications provided
| Responsible Party: | DUSA Pharmaceuticals, Inc. |
| ClinicalTrials.gov Identifier: | NCT01475955 History of Changes |
| Other Study ID Numbers: | CP0105 |
| Study First Received: | November 15, 2011 |
| Last Updated: | November 21, 2012 |
| Health Authority: | United States: Food and Drug Administration |
Additional relevant MeSH terms:
|
Keratosis Keratosis, Actinic Skin Diseases Precancerous Conditions Neoplasms Aminolevulinic Acid |
Photosensitizing Agents Radiation-Sensitizing Agents Physiological Effects of Drugs Pharmacologic Actions Dermatologic Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on May 21, 2013